Montauk Metals Inc
MTK
Navco Pharmaceuticals Inc
NAV
MYND Life Sciences Inc
MYND
Consolidated Lithium Metals Inc
CLM
O2Gold Inc
OTGO.H
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Cost of revenue | ||||||||||
Gross profit | ||||||||||
Operating expense | 69.10%530.19K | -0.12%335.1K | -43.09%341.82K | -53.75%1.61M | 0.51%357.9K | -26.67%313.53K | -28.23%335.5K | -73.00%600.61K | -40.13%3.48M | -83.80%356.1K |
Selling and administrative expenses | 106.42%450.64K | 28.32%253.08K | -44.58%257.48K | -13.98%1.14M | -1.19%257.01K | -15.78%218.31K | -38.37%197.22K | -3.74%464.62K | -57.43%1.32M | -74.50%260.11K |
-General and administrative expense | 106.42%450.64K | 28.32%253.08K | -44.58%257.48K | -13.98%1.14M | -1.19%257.01K | -15.78%218.31K | -38.37%197.22K | -3.74%464.62K | -57.43%1.32M | -74.50%260.11K |
Other operating expenses | -16.46%79.55K | -40.68%82.03K | -37.98%84.34K | -78.16%470.38K | 5.11%100.9K | -43.44%95.22K | -6.21%138.27K | -92.19%135.99K | -20.23%2.15M | -91.85%95.99K |
Operating profit | -69.10%-530.19K | 0.12%-335.1K | 43.09%-341.82K | 53.75%-1.61M | -0.51%-357.9K | 26.67%-313.53K | 28.23%-335.5K | 73.00%-600.61K | 40.13%-3.48M | 83.80%-356.1K |
Net non-operating interest income (expenses) | -20.50%2.83K | -21.85%3.56K | 142.50%38.48K | 49.95%26.55K | 136.77%2.57K | 238.99%3.56K | 78.08%4.55K | 21.95%15.87K | 132.86%17.7K | -56.53%1.09K |
Non-operating interest income | -20.50%2.83K | -21.85%3.56K | 142.50%38.48K | 49.95%26.55K | 136.77%2.57K | 238.99%3.56K | 78.08%4.55K | 21.95%15.87K | 330.60%17.7K | -54.68%1.09K |
Other net income (expenses) | 106.81%827 | -73.55%1.12K | -56.84%3.31K | -99.51%87 | 101.16%319 | -129.21%-12.14K | -1.92%4.23K | 1,141.79%7.68K | -43.47%17.67K | -206.26%-27.47K |
Gain on sale of security | 106.81%827 | -73.55%1.12K | -56.84%3.31K | -99.51%87 | 101.16%319 | -129.21%-12.14K | -1.92%4.23K | 1,141.79%7.68K | 2,435.15%17.67K | -482.38%-27.47K |
Income before tax | -63.46%-526.53K | -1.14%-330.43K | 48.01%-300.02K | 54.05%-1.58M | 7.18%-355.02K | 16.32%-322.12K | 29.06%-326.71K | 73.91%-577.06K | 40.97%-3.44M | 82.37%-382.48K |
Income tax | ||||||||||
Earnings from equity interest net of tax | ||||||||||
Net income | -63.46%-526.53K | -1.14%-330.43K | 48.01%-300.02K | 54.05%-1.58M | 7.18%-355.02K | 16.32%-322.12K | 29.06%-326.71K | 73.91%-577.06K | 40.97%-3.44M | 82.37%-382.48K |
Net income continuous operations | -63.46%-526.53K | -1.14%-330.43K | 48.01%-300.02K | 54.05%-1.58M | 7.18%-355.02K | 16.32%-322.12K | 29.06%-326.71K | 73.91%-577.06K | 40.97%-3.44M | 82.37%-382.48K |
Noncontrolling interests | ||||||||||
Net income attributable to the company | -63.46%-526.53K | -1.14%-330.43K | 48.01%-300.02K | 54.05%-1.58M | 7.18%-355.02K | 16.32%-322.12K | 29.06%-326.71K | 73.91%-577.06K | 40.97%-3.44M | 82.37%-382.48K |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | ||||||||||
Net income attributable to common stockholders | -63.46%-526.53K | -1.14%-330.43K | 48.01%-300.02K | 54.05%-1.58M | 7.18%-355.02K | 16.32%-322.12K | 29.06%-326.71K | 73.91%-577.06K | 40.97%-3.44M | 82.37%-382.48K |
Diluted earnings per share | -63.46%-0.0017 | -1.12%-0.0011 | 48.05%-0.001 | 0.00%-0.01 | -0.006 | 16.42%-0.0011 | 29.09%-0.0011 | 81.00%-0.0019 | 50.00%-0.01 | 0 |
Basic earnings per share | -63.46%-0.0017 | -1.12%-0.0011 | 48.05%-0.001 | 0.00%-0.01 | -0.006 | 16.42%-0.0011 | 29.09%-0.0011 | 81.00%-0.0019 | 50.00%-0.01 | 0 |
Dividend per share | ||||||||||
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.